Pfizer Inc.
Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors

Abstract:

Provided herein are substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors, processes to make said compounds, and methods comprising administering said compounds to a mammal in need thereof.